2015 Edelweiss Insurance Brokers Limited (EIBL) Super Top Up Policy.

Slides:



Advertisements
Similar presentations
Remedy Statistics April 2009 May 28th 2009 Paris Desktop Support Analysis only done with Remedy tickets (Incident-Task-Request) (GRS requests are not included.
Advertisements

JinkoSolar Holding Co., Ltd. Q Earnings Call Presentation June 7, 2013.
© 2013 Sri U-Thong Limited. All rights reserved. This presentation has been prepared by Sri U-Thong Limited and its holding company (collectively, “Sri.
United India Insurance Company Limited
1 K.M. Dastur Reinsurance Brokers Private Limited Exclusive Tailor-made Group Mediclaim Policy Highlights. All covers of the normal Mediclaim Policy Plus:……………….
It is a fully loaded Top end Floater Policy for the entire family with High Sum Insured Extended Benefits No Sub Limits No Capping on Room Rent Restoration.
It is a fully loaded Top end Floater Policy for the entire family with High Sum Insured Extended Benefits No Sub Limits No Capping on Room Rent Restoration.
STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING.
Irish recovery? Pär Magnusson
Innovations in Structured Products October 25, 2010 An Innovator’s Dilemma?
JOB FUNCTION EVALUATION Lowering Your Accident Costs.
Star Super Surplus Insurance Policy Salient Features.
Star Health and Allied Insurance Co. Ltd. Presentation on Star Super Surplus Presentation On Star Super Surplus.
ICSL – FHPL Mediclaim Policy How to Access you Mediclaim Card.
Star Health and Allied Insurance Co. Ltd. Presentation on Star Super Surplus Presentation On Star Super Surplus.
Insurer : Bajaj Allianz General Insurance Co. Ltd
STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING Senior Citizens Senior.
Chola MS HELP – Health Claims Presentation M/s VA Tech Wabag Group Health Cover
STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING STAR HEALTH AND ALLIED INSURANCE COMPANY LIMITED PERSONAL & CARING.
PRODUCTIVITY – THE PICTURE FOR THE UK & THE WEST MIDLANDS SUSTAINING COMPETITIVENESS CONFERENCE – THE BELFRY RHYS HERBERT SENIOR ECONOMIST 6 JULY 2012.
MESSAGING IN THE MEDIA TOP 10 DRUGS BASED ON CREDIBILITY INDEX IN THE LITERATURE JOHN KNAPP, DIRECTOR OF ANALYTICS MAY 2009 Your use of these materials.
Therapeutic area breakdown of lead projects in development for first launch in 2005 APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM ©
Dunedin Enterprise Investment Trust PLC General Meeting – October 2013, Voting Analysis.
© 2013 The McGraw-Hill Companies, Inc. All rights reserved. Ch 8 Privacy Law and HIPAA.
Place Client Logo Here Oil Market Outlook Paul Horsnell Head of Commodities Research, Barclays Capital Intertanko Singapore Tanker Event 30 March 2006.
Global R&D expenditure, development times, global pharmaceutical sales and new molecular entity output MARCH 2008 SOURCE: CMR INTERNATIONAL.
© 2014 Gartner, Inc. and/or its affiliates. All rights reserved. Gartner is a registered trademark of Gartner, Inc. or its affiliates. This publication.
2005/2006 Expenditure on biotech derived entities had remained constant APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS PROGRAM © THOMSON REUTERS.
Number of pharmaceutical patent applications and granted patents for 5 major patent issuing authorities JUNE 2008 SOURCE: DERWENT WORLD PATENTS.
Investec Asset Management Update on Asset Class Returns December 2015.
Availability of High-Quality API for India, China and Rest of World MARCH 2008 David Harding, API Intelligence, Thomson Reuters Source: NEWPORT HORIZON.
2016 BUDGET SUMMARY. This presentation has been prepared by John Blangiardo and Apogee Financial Planning Limited ABN , a member of the National.
Permission to reprint or distribute any content from this presentation requires the prior written approval of Standard & Poor’s. Copyright © 2011 Standard.
The secure site rendering issue (all navigation crushed together as a list at the top of the page) is a compatibility issue with Internet Explorer only.
Copyright © 2012, Oracle and/or its affiliates. All rights reserved. Oracle Proprietary and Confidential. 1.
Health Savings Accounts (HSAs)
RaboDirect Financial Health Barometer 2016
Summary of financial results for the period 1-6/2017
JinkoSolar Holding Co., Ltd.
JinkoSolar Holding Co., Ltd.
Superannuation changes and you
Summary of financial results for the period 1-12/2016
BIOLOGY / CHEMISTRY CITATIONS GROWTH
Selecting the right provider
Under-rated assets in an over-priced world
Texas Health Care Network - Employer Presentation
Automation in an XML Authoring Environment
GROUP MEDICLAIM POLICY ( )
Messaging in the Media TOP 10 AUDIENCES BY THERAPY AREA
Self-Registration walk-through
, R&D expenditure showed 6% growth annually
Pamplona Credit Opportunities Fund
ACBO FALL 2012 CONFERENCE PANEL OUTLINE
Market linked debentures
Solanco School District
Vital Protection Underwritten by: LifeShield National Insurance Co.
Environmental Upgrade Finance
Motivation for 36OU Open Rack
Pipeline size of Major companies had grown at a steadier rate than that of smaller companies APRIL 2007 SOURCE: CMR INTERNATIONAL PERFORMANCE.
Development time for new molecular entities first launched onto the world market between MARCH 2008 SOURCE: CMR INTERNATIONAL PERFORMANCE METRICS.
Cycle times decreased in larger but not smaller, companies
Foreword GROUP HEALTH INSURANCE
TITLE PRESENTATIONDATE AUTHOR JOBTITLE.
Proportion of total R&D expenditure by function in 2005
VitalaCare Underwritten by: LifeShield National Insurance Company
© 2013 Sri U-Thong Limited. All rights reserved
Group Mediclaim Policy
Emotional Intelligence: The Core of Family Offices
2019 MEDICARE AGE-IN STUDY SENIOR MARKET INSIGHTS SERVICE Part IV
Presentation transcript:

2015 Edelweiss Insurance Brokers Limited (EIBL) Super Top Up Policy

Today’s Healthcare Cost Concern 2 Increased Healthcare Cost Advent of new Lifestyle diseases Corporatisation of Healthcare Advancement of Medical Technology Increasing Awareness General Inflation

Current Solutions to the Healthcare Cost Concern 3 Group Mediclaim Policy Advancement of Loan Any other option???

Current Solutions to the Healthcare Cost Concern 4 Confusion of abundance Restricted Benefits Pre-policy check up High Premium Any other Solution??? Personal Mediclaim Policy

Alternative Solution 5 Confusion of abundance Restricted Benefits Pre-policy checkup High Premium Super Top Up Policy for Publicis Employees, specially designed by EIBL with Oriental Insurance Co. Ltd.

6 1.This policy has coverage for employees and dependants which include spouse, children, parents or parent in laws. The identical family covered under Group Mediclaim will be covered for Super Top Up Policy. 2.No Medical check up / pre policy checkups. 3.The policy can be issued on family floater sum insured basis i.e. Single sum insured would be applicable for entire family and the same can be utilised by any of the insured family member. 4.Single documentation required for processing claims and hence employee need not to arrange any other documents for Super Top Up policy. 5.Paramount Health Services (TPA) Pvt. Ltd., will service the cashless and reimbursement claims under Super Top Up policy. 6.This policy will trigger only when the aggregate of covered hospitalisation expenses exceeds the Sum Insured under Group Mediclaim policy. 7.Employee has option to select sum insured from the choice of the sum insured from Rs.1 lakh to 20 Lakh. 8.This policy will be governed by Terms, conditions, exclusions and warranties of the Basic Group Mediclaim Policy. Highlights of the Policy

Benefits 7 Claims under this Policy shall be payable only if the aggregate of covered Medical Expenses in respect to Hospitalisation(s) of Insured Person exceeds the Sum Insured under the Group Mediclaim Policy availed by Publicis The benefits covered are as below: 1.All the coverage's available under Publicis Group Mediclaim will be carried forward. 2.In-patient Treatment -Medical expenses for room rent, boarding expenses, nursing, ICU, medical practitioner, anesthesia, blood, oxygen, operation theatre charges, surgical appliances, medicines, drugs and consumables, diagnostic procedures, cost of prosthetic and other devices or equipment if implanted internally during a Surgical Procedure. 3.Waiver of Pre Existing diseases ; 1st year, 2nd year exclusion ;first 30 days exclusion. 4.Pre-Post hospitalization 5.Day Care Expenses 6.Claims paid under basic policy in which claim amount exceeds the sum insured of basic policy, super top up policy will pay the balance claim amount.

Exclusions under Super Top Up Policy 8 The following expenses will not be covered under the policy: 1.Maternity Expenses, Pre & Post Natal Expenses, Baby Day 1 cover expenses. 2.Co-pay, Capped Diseases and Non admissible expenses deducted under Basic GMC policy of Publicis 3.All Exclusions of Basic GMC Policy like Cosmetic Surgery, Dental and cost of Spectacle, treatment of Obesity. 4.Domiciliary Hospitalization, Naturopathy, Stem Cell Surgery. Please note that all the terms and conditions applied in the Group Base Mediclaim policy will be applicable in the Top-up Policy

Special Features 9 1.TPA : Same TPA (i.e) Paramount Health Services (TPA) Pvt. Ltd. for basic and Top-Up policy. Employee need not to prepare two set of documents. 2. Financial Saving: Financial saving by avoiding dent to your saving when hospitalisation cost exceeds the sum insured of your basic Group Mediclaim.

Premium (Excluding Service Tax) 10 Premium Rates applicable Top Up Sum InsuredPremiumService Tax Total Payable 1 Lakhs Lakhs Lakhs Lakhs Lakhs Lakhs Lakhs

Insurance Broking services offered by Edelweiss Insurance Brokers Limited a Direct Broker (General) registered under IRDA License No.: 295 valid for a period from March 24, 2014 till March 23, Registered Office: Edelweiss House, Off CST Road, Kalina, Mumbai – ; Tel. (022) Corporate Office: Unit No. 102, 10 th Floor, Sakhar Bhavan, 230, Nariman Point, Mumbai – ; Tel. (022) Disclaimer This Information Package is distributed by Edelweiss Insurance Brokers Limited (hereinafter “Edelweiss”) on a strictly private and confidential and on a need to know basis. This Information Package and the information and projections contained herein may not be disclosed, reproduced or used in whole or in part for any purpose or furnished to any other person or persons. The Persons who are in possession of this Information package or may come in possession at a later day, hereby undertakes to observe the restrictions contained herein. The information contained herein is of a general nature and is not intended to address the facts and figures of any particular individual or entity. The information contained herein is from publicly available data or other sources believed to be reliable, but we do not represent that it is accurate or complete and it should not be relied on as such. The content provided here treats the subjects covered here in condensed form. It is intended to provide a general guide to the subject matter and should not be relied on as a basis for business decisions. No one should act upon such information without making appropriate additional professional advice after a thorough examination of the particular situation. This Information Package is distributed by Edelweiss upon the express understanding that no information herein contained has been independently verified. Further, no representation or warranty expressed or implied is made nor is any responsibility of any kind accepted with respect to the completeness or accuracy of any information as may be contained herein. Also no representation or warranty expressed or implied is made that such information remains unchanged in any respect as of any date or dates after those stated herein with respect to any matter concerning any statement made in this Information Package. Edelweiss or any of its affiliates/ group companies/ directors/ employees/ agents/consultants shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information and shall have no liability (including liability to any person by reason of negligence or negligent misstatement) for any statements, opinions, information or matters (express or implied) arising out of, contained in or derived from, or for any omissions from the Information Package and any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this information package and/or further communication in relation to this information package. All recipients of the Information Package should make their own independent evaluations and should conduct their own investigation and analysis and should check the accuracy, reliability and completeness of the Information and obtain independent and specific advice from appropriate professional advisers, as they deem necessary. Where this Information Package summarizes the provisions of any other document, that summary should not be relied upon and the relevant. The information contained in this document is confidential in nature and the recipient is receiving all such information on the express condition of confidentiality unless expressly authorized in writing by Edelweiss. If you are not the intended recipient, you must not disclose or use the information in this document in any way whatsoever. If you received it in error, please inform us immediately by return and delete the document with no intention of its being retrieved by you. We do not guarantee the integrity of any s or attached files and are not responsible for any changes made to them by any other person. The data contained in this presentation is only indicative / illustrative. This information is subject to change without any prior notice. Edelweiss reserves the right to make modifications and alterations to this statement as may be required from time to time. However, Edelweiss is under no obligation to update or keep the information current. This presentation and its respective contents do not constitute an offer or solicitation of any Insurance Broking services. Insurance is the subject matter of solicitation. Disclaimer